52-year-old patient with interstitial pneumonia, dysphagia and Reynaud's syndrome

1. Насонов Е. Л. Ревматология: клинические рекомендации.2-е изд., испр. и доп. М.: ГЭОТАР-Медиа 2011:752.

2. Ивашкин В. Т., Маев И. В., Трухманов А. С. и др. Дисфагия. Клинические рекомендации. Росс гастроэнтерол ассоциация 2014: М.

3. Corte t., Du Bois R., Wells A. Connective tissue diseases. Murray and Navel’s Textbook of Respiratory Medicine.6 ed. USA: Elvsevier inc 2016;1165-87.

4. Аверьянов А. В., Лесняк В. Н., Коган Е. А. Редкие заболевания легких: диагностика и лечение. Под ред. А. В. Аверьянова. М.ООО «Издательство «Медицинское информационное агентство» 2016:140-52.

5. Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 1994 Sep; 37(9):1265-82.

6. Tavakol M. E., Fatemi A., Karbalaie A., Emrani Z., Erlandsson B­E. Nailfold Capillaroscopy in Rheumatic Diseases: Which Parameters Should Be Evaluated? Biomed Res Int. 2015; 2015:974530.

7. Van den Hoogen F., Khanna D., Fransen J., et al. Classification criteria for systemic sclerosis: an American college of rheumatology / European league against rheumatism collaborative initiative. Ann. Rheum. Dis 2013(72):1747-55.

8. Lesley Ann Saketkoo, Jeanette H. Magnus and Mittie K. Doyle.The Primary Care Physician in the Early Diagnosis of Systemic Sclerosis: the Cornerstone of Recognition and Hope. Am J Med Sci 2014 January; 347(1).

9. Shah R. M., Jimenez S., Wechsler R. Significance of ground glass opacity on HRCT in long term follow up of patient with systemic Sclerosis. J. Torac. Imaging 2007(22):120-124.

10. Varga J. Sistemic sclerosis: An update//Bull NYU Hosp. Jt. Dis.-2008.-Vol.66.-P.198-202; Steele R., Hudson M., Lo E. et al. Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis//Arthritis Care Res (Hoboken). -2012. - Apr; Vol. 64 (4).-P. 519524.

11. Goh N. S., Desay S. R., Veeraraghavan S., Hansell D. M., Copley S. J., Maher T. M. et al. Interstitial lung disease in systemic sclerosis: A simple staging system. Am. J. Respir. Crit. Care Med 2008(177):124854.

12. Hoyles R. K., Ellis R. W., Wellsbury J. et al. A Multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis and Rheumatism 2006. 12(54):3962-70.

13. Cappelli S., Guiducci S., Randone S., Cerinic M. Immunosuppression for interstitial lung desiase in systemic sclerosis. Eur. Respir. Rev 2013; sep 122(129):236-43.

14. M. Rao Kotnur, P. Suresh, V. Siva Prasad Reddy, T. Sharma, N. A. Salim. Systemic Sclerosis with Multiple Pulmonary Manifestation. Journal of Clinical and Diagnostic Research 2016 Jun, 10(6): OD16-OD1716.

15. Joshua J. Solomon, Amy L. Olson, Aryeh Fischer, Todd Bull, Kevin K. Brown, and Ganesh Raghu. Scleroderma lung disease. Eur Respir Rev 2013 Mar 1; 22(127):6-19.